Category: Accuray Inc.
AliveCor's interim-ish CEO Euan Thomson talks about the data-driven future, why he jumped ship at Accuray and how to navigate the intersection between the tempered medical device world and the wanton nimbleness of Silicon Valley.
When Euan Thomson left Accuray (NSDQ:ARAY) in 2012 after more than 10 years, it wasn't so much for greener pastures as it was for swifter currents.
Here's a look at some of the top Wall Street stories for medical device companies this week.
, Cardiovascular Systems Inc.
, Edwards Lifesciences
, Endo Health
, Hansen Medical Inc.
, Intuitive Surgical Inc.
, Johnson & Johnson
, Morgan Stanley
, Accuray Inc.
, GI Dynamics
Medtech stocks flipped the script last month, having underperformed the S&P 500 by 4% after out-performing the index by nearly 5% during the 1st quarter, according to a Morgan Stanley analysis.
The medical device sector under-performed the S&P 500 index in April after a sharp swing over-performance during the 1st quarter, according to analysts at Morgan Stanley.
The 30 medtech stocks Morgan Stanley covers collectively under-performed the S&P by 4.1%, after besting the index by 4.9% during the 1st quarter.
California medtech maker Accuray boosts its full-year revenue outlook after posting Q3 2014 sales nearly 40% higher than last year.
Radiosurgery systems maker Accuray (NSDQ:ARAY) sees continued momentum on the horizon as a boost in Q3 sales prompts an updated, increased full-year outlook.
Radiosurgery systems maker Accuray lands summary judgment in trade secrets lawsuit filed by former supplier Rotary Systems.
California medtech maker Accuray (NSDQ:ARAY) tallied a win in a trade secrets lawsuit filed by a former supplier, announcing that a Minnesota court awarded summary judgment against Rotary Systems.
Accuray slashes Q2 losses and ups its earnings expectations for the year, prompting a 13% boost from Wall Street.
California radiation oncology systems maker Accuray (NSDQ:ARAY) scored major Wall Street points with its 2nd quarter financial report, with shares soaring on news of lowered losses and increased guidance for the year.
Accuray shares are up today after the medical device company reports reduced losses and increased profit margins.
Accuray (NSDQ:ARAY) shares gained nearly 10% this morning after the medical device company reported lower fiscal 1st-quarter losses and an improved profit margin.
Sunnyvale, Calif.-based Accuray logged losses of $15.5 million, or -21¢ per share, on sales of $76.6 million for the 3 months ended Sept. 30, for a loss reduction of 35.6% on a sales decline of 7.4%.